Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone treatment for opioid use disorder in Ibadan, Nigeria
PACTR202609586084097Not yet recruiting
- Sponsor
- Self-sponsored
- Start
- Nov 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of methadone in opioid use disorder (OUD) (2 arms), sponsored by Self-sponsored. Primary endpoints: Retention in treatment at 12 months and Change in opioid use. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
methadone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on PACTR202609586084097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202609586084097.